Loading insider details...
Latest Form 4 (Jun 11, 2026): Exercise/Conversion of 1,429 AXSM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 1,429 | n/a |
| Jun 9, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,721 | n/a |
| Jun 5, 2026 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/Award | 8,000 | n/a |
| Jan 13, 2026 | Zymeworks Inc. (ZYME) | Grant/Award | 11,500 | n/a |
| Jun 10, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 3,166 | n/a |
| Jun 9, 2025 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/Award | 3,500 | n/a |
| Feb 25, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,312 | n/a |
| Dec 12, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 31,000 | n/a |
| Jun 11, 2024 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 5,799 | n/a |
| May 30, 2024 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/Award | 2,750 | n/a |